MBL2 and bacterial infectious disease: Reduced levels of circulating MBL are associated with an increased risk of invasive pneumococcal disease, other bacterial infections (e.g., Staphylococcus aureus, Pseudomonas aeruginosa, Clostridium difficile), sepsis, and death from pneumonia (60–62).